Table 2.
Multivariate Cox regression analysis for overall survival and tumor recurrence-free survival of HCC patients.
| Variables | Overall survival | Tumor recurrence-free survival | ||||
|---|---|---|---|---|---|---|
| P value | HR | 95%CI | P value | HR | 95%CI | |
| HBeAg | – | – | – | 0.05 | 1.858 | 1.000–3.458 |
| PT (seconds) | 0.023 | 2.246 | 1.118–4.513 | – | – | – |
| AFP (ng/mL) | ||||||
| 20–400 vs. ≤ 20 | 0.108 | 2.213 | 0.840–5.831 | 0.233 | 1.438 | 0.792–2.613 |
| > 400 vs. ≤ 20 | 0.001 | 4.091 | 1.715–9.760 | 0.005 | 2.199 | 1.265–3.822 |
| Pathologic diagnosis | ||||||
| MVI presence vs. absence | – | – | – | 0.022 | 1.780 | 1.085–2.920 |
| Tumor diameter (cm) | 0.004 | 1.123 | 1.038–1.216 | 0.023 | 1.072 | 1.010–1.138 |
HbeAg hepatitis B e antigen, PT prothrombin time, AFP α-fetoprotein.